A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Yimei Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Radiation …. Hauptthemen laut MEDLINE: Cone-Beam Computed Tomography, Lung Neoplasms, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Image-Guided. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Background
The aim of the study was to establish a weighted comprehensive evaluation model (WCEM) of image registration for cone‐beam computed tomography (CBCT) guided lung cancer radiotherapy that considers the geometric accuracy of gross target volume (GTV) and organs at risk (OARs), and assess the registration accuracy of different image registration methods to provide clinical references.
Methods
The planning CT and CBCT images of 20 lung cancer patients were registered using diverse algorithms (bony and grayscale) and regions of interest (target, ipsilateral, and body). We compared the coverage ratio (CR) of the planning target volume (PTV CT ) to GTV CBCT , as well as the dice similarity coefficient (DSC) of the GTV and OARs, considering the treatment position across various registration methods. Furthermore, we developed a mathematical model to assess registration results comprehensively. This model was evaluated and validated using CRFs across four automatic registration methods.
Results
The grayscale registration method, coupled with the registration of the ipsilateral structure, exhibited the highest level of automatic registration accuracy, the DSC were 0.87 ± 0.09 (GTV), 0.71 ± 0.09 (esophagus), 0.74 ± 0.09 (spinal cord), and 0.91 ± 0.05 (heart), respectively. Our proposed WCEM proved to be both practical and effective. The results clearly indicated that the grayscale registration method, when applied to the ipsilateral structure, achieved the highest CRF score. The average CRF scores, excellent rates, good rate and qualification rates were 58 ± 26, 40%, 75%, and 85%, respectively.
Conclusions
This study successfully developed a clinically relevant weighted evaluation model for CBCT‐guided lung cancer radiotherapy. Validation confirmed the grayscale method's optimal performance in ipsilateral structure registration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Radiation Oncology, Guangdong Provincial Clinical Research Center for Cancer, Su…
ORCID-Profile: Yinglin Peng
Förderung
- National Key Research and Development Program of China
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Liu, Y., Chen, M., Fang, J., Xiao, L., Liu, S., Li, Q., Qiu, B., Huang, R., Zhang, J., & Peng, Y. (2024). A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15320
Vancouver
Liu Y, Chen M, Fang J, Xiao L, Liu S, Li Q, et al. A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15320
BibTeX
@article{Liu2024,
author = {Liu, Yimei and Chen, Meining and Fang, Jianlan and Xiao, Liangjie and Liu, Songran and Li, Qiwen and Qiu, Bo and Huang, Runda and Zhang, Jun and Peng, Yinglin},
title = {A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15320}
}
EUVIMED